Inventor · disambiguated record
Donato Barbato
Also filed as: BARBATO DONATO
9 granted patents·20 pending applications·57 citations·filing 2017–2025
86Inventor score
Files withADVANCED ACCELERATOR APPLICATIONS SA11ADVANCED ACCELERATOR APPLICATIONS ITALY SRL5NOVARTIS AG5ADVANCED ACCELERATOR APPLICATIONS2ADVANCED ACCELERATOR APPLICATIONS INT S A2
Top patents by PatentIndex Score
29 records- 0194US11904027B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS·Filed 2020·Granted Feb 20, 2024·9 cites·26 claims
- 0294US10596276B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2018·Granted Mar 24, 2020·21 cites·24 claims
- 0394US10596278B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2018·Granted Mar 24, 2020·23 cites·25 claims
- 0493US12168063B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Dec 17, 2024·1 cites·30 claims
- 0593US12161732B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Dec 10, 2024·1 cites·30 claims
- 0693US12151003B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Nov 26, 2024·1 cites·30 claims
- 0793US12144873B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Nov 19, 2024·1 cites·30 claims
- 0890US12491272B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Dec 9, 2025·0 cites·30 claims
- 0990US12415003B2Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Granted Sep 16, 2025·0 cites·30 claims
- 1085US2024075171A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS·Filed 2023·Application pending·0 cites
- 1185US2025295820A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2025·Application pending·0 cites
- 1279US2025213734A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2025·Application pending·0 cites
- 1369US2025332301A1Stable, concentrated radiopharmaceutical compositionNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1466US2020131224A1Methods for Synthesis of Radionuclide ComplexADVANCED ACCELERATOR APPLICATIONS ITALY S R L·Filed 2019·Application pending·0 cites
- 1565US2021316019A1Methods for Synthesis of Radionuclide ComplexADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2019·Application pending·0 cites
- 1664US2025025583A1Method of treatment of neuroendocrine tumorsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2024·Application pending·0 cites
- 1764US2022273826A1Prostate specific membrane antigen (psma) ligands and uses thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1863US2022041649A1Methods for Synthesis of Radionuclide ComplexADVANCED ACCELERATOR APPLICATIONS ITALY S R L·Filed 2021·Application pending·0 cites
- 1961US2021379212A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2021·Application pending·0 cites
- 2061US2021379213A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS SA·Filed 2021·Application pending·0 cites
- 2160US2022401593A1Stable, concentrated radiopharmaceutical compositionNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2257US2022031872A1Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128ADVANCED ACCELERATOR APPLICATIONS INT S A·Filed 2021·Application pending·0 cites
- 2357US2020030465A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2018·Application pending·0 cites
- 2457US2020030466A1Stable, concentrated radionuclide complex solutionsADVANCED ACCELERATOR APPLICATIONS ITALY SRL·Filed 2018·Application pending·0 cites
- 2554US2023330278A1Methods for radiolabelling psma binding ligands and their kitsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2654US2023165980A1Methods for radiolabeling psma binding ligands and their kitsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2752US2022008566A1Pharmaceutical Composition Comprising a Radiolabeled GRPR Antagonist and a SurfactantADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2019·Application pending·0 cites
- 2845US2022072166A1Method of treatment of neuroendocrine tumorsADVANCED ACCELERATOR APPLICATIONS S A·Filed 2019·Application pending·0 cites
- 2940US2020038526A1Lyophilized Compositions Comprising Rhannexin V-128, Process for Their Preparation and Their Use for Preparing Formulations Containing 99MTc-Rhannexin V-128ADVANCED ACCELERATOR APPLICATIONS INT S A·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Donato Barbato files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →